Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (7463)	1/13/2000 1:34:00 PM
From: schadenfreude	Respond to of 9719

From the we must be near a top department... My father-in-law called me last night from Japan wanting some investment advice. It seems his broker is telling him that genomics is hot and that Celera is the stock to buy. I told him that the sector is probably over-extended right now and may be due for a selloff, but longer term this is a very exciting area. I suggested dollar cost averaging in over a period of months, but said I would choose Incyte or Millenium if it were my own my money. By the way, Naz Japan is now open. Japanese investors can now purchase any Nasdaq stock, I believe. There is a lot of buzz around biotech over there. Sounds like more volatility to me.